EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023–2025

Ryuha Omachi iD, Kazuo Imai iD, Akihiro Sato, Masashi Tanaka, Hitomi Mizushina, Keita Takeuchi, Nobuaki Mori iD, Takuya Maeda iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.01367-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Ryuha Omachi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Saitama Medical University, Saitama, Japan. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Anti-Bacterial Agents, Mycoplasma Infections, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing prevalence of Mycoplasma genitalium (MG) strains harboring macrolide and quinolone resistance-associated mutations (MRMs and QRMs, respectively) is a growing global concern. However, data on resistance patterns and genetic diversity in Japan remain limited. This study investigated MRMs and QRMs, genetic diversity using mgpB and MG309 typing, and their association with treatment outcome in MG strains collected in Tokyo, Japan, between 2023 and 2025. Between 2023 and 2025, 188 clinical samples from 162 MG-positive patients were analyzed. Resistance mutations in 23S rRNA, parC , and gyrA were sequenced, and molecular typing was performed. Treatment outcomes were assessed using test-of-cure results. MRMs in 23S rRNA and QRMs in parC S83I and gyrA were identified in 94.4%, 65.5%, and 22.5% of samples, respectively. Dual-class resistance (MRMs + QRMs) was found in 89.4% of strains. Phylogenetic analysis based on mgpB and MG309 typing revealed the emergence of dual-class drug-resistant clonal complexes, particularly those harboring mgpB alleles 79, 140, 161, and 184. Dual-QRMs were significantly associated with quinolone treatment failure (52.4% vs 23.5%, P = 0.016). Dual-class drug-resistant MG strains, including emerging clonal complexes, are spreading in Tokyo, Japan. These findings emphasize the need for continued molecular surveillance and prudent antimicrobial use to preserve treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma genitaliumAnti-Bacterial AgentsMycoplasma InfectionsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsRNA, Ribosomal, 23STokyoFemaleQuinolonesDNA GyraseMaleMacrolidesPhylogenyAdultDNA Topoisomerase IVMutationMiddle AgedDrug Resistance, BacterialJapan

Stichwörter der Autor:innen

Mycoplasma genitaliumdrug resistancemacrolidequinolone

Substanzen

Anti-Bacterial AgentsRNA, Ribosomal, 23SQuinolonesDNA GyraseMacrolidesDNA Topoisomerase IV

Autor:innen und Institutionen

  • Department of Clinical Laboratory Medicine, Saitama Medical University, Saitama, Japan.
  • Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan.
  • KARADA Internal Medicine Clinic, Tokyo, Japan.
  • Department of Medicine, Division of Clinical Infectious Diseases, Showa Medical University School of Medicine, Tokyo, Japan.

ORCID-Profile: Ryuha Omachi, Kazuo Imai, Nobuaki Mori, Takuya Maeda

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Omachi, R., Imai, K., Sato, A., Tanaka, M., Mizushina, H., Takeuchi, K., Mori, N., & Maeda, T. (2026). Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023–2025. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01367-25

Vancouver

Omachi R, Imai K, Sato A, Tanaka M, Mizushina H, Takeuchi K, et al. Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023–2025. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01367-25

BibTeX
@article{Omachi2026,
  author = {Omachi, Ryuha and Imai, Kazuo and Sato, Akihiro and Tanaka, Masashi and Mizushina, Hitomi and Takeuchi, Keita and Mori, Nobuaki and Maeda, Takuya},
  title = {Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023–2025},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.01367-25}
}
Kostenlos starten →